Factor | Lugsomya2018 (20009)

10.1089/mdr.2017.0042

Therapeutic enrofloxacin use

Swine | Grower-finisher

1

Description

Enrofloxacin use broken up by treatment group

Resistance Outcomes

Resistance Microbe Outcome
Enrofloxacin
/
Escherichia coli
See: Figure 2 AMR+ (%) AMR- (%) Total (n)
Therapeutic AMU 41.40 70
No AMU 34.30 67